Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.

Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z, Li J.

Int J Nanomedicine. 2018 Mar 9;13:1425-1442. doi: 10.2147/IJN.S156616. eCollection 2018. Review.

2.

Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.

Iezzi ME, Policastro L, Werbajh S, Podhajcer O, Canziani GA.

Front Immunol. 2018 Feb 19;9:273. doi: 10.3389/fimmu.2018.00273. eCollection 2018. Review.

3.

Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.

Hu C, Chen X, Huang Y, Chen Y.

Sci Rep. 2018 Feb 2;8(1):2274. doi: 10.1038/s41598-018-20715-4.

4.

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics.

Gao L, Yu J, Liu Y, Zhou J, Sun L, Wang J, Zhu J, Peng H, Lu W, Yu L, Yan Z, Wang Y.

Theranostics. 2018 Jan 1;8(1):92-108. doi: 10.7150/thno.21074. eCollection 2018.

5.

Targeted Delivery of siRNA Therapeutics to Malignant Tumors.

Leng Q, Woodle MC, Mixson AJ.

J Drug Deliv. 2017;2017:6971297. doi: 10.1155/2017/6971297. Epub 2017 Nov 9. Review.

6.

Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease.

Mann AP, Scodeller P, Hussain S, Braun GB, Mölder T, Toome K, Ambasudhan R, Teesalu T, Lipton SA, Ruoslahti E.

Nat Commun. 2017 Nov 10;8(1):1403. doi: 10.1038/s41467-017-01096-0. Erratum in: Nat Commun. 2018 Mar 9;9(1):1070.

7.

Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.

Cureton N, Korotkova I, Baker B, Greenwood S, Wareing M, Kotamraju VR, Teesalu T, Cellesi F, Tirelli N, Ruoslahti E, Aplin JD, Harris LK.

Theranostics. 2017 Aug 29;7(15):3715-3731. doi: 10.7150/thno.19678. eCollection 2017.

8.

Neuropilin-1 is a glial cell line-derived neurotrophic factor receptor in glioblastoma.

Sun S, Lei Y, Li Q, Wu Y, Zhang L, Mu PP, Ji GQ, Tang CX, Wang YQ, Gao J, Gao J, Li L, Zhuo L, Li YQ, Gao DS.

Oncotarget. 2017 Jun 27;8(43):74019-74035. doi: 10.18632/oncotarget.18630. eCollection 2017 Sep 26.

9.

Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K.

Front Immunol. 2017 Oct 10;8:1228. doi: 10.3389/fimmu.2017.01228. eCollection 2017. Review.

10.

Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas.

Ren Y, Sagers JE, Landegger LD, Bhatia SN, Stankovic KM.

Sci Rep. 2017 Oct 10;7(1):12922. doi: 10.1038/s41598-017-13032-9.

11.

In vivo cation exchange in quantum dots for tumor-specific imaging.

Liu X, Braun GB, Qin M, Ruoslahti E, Sugahara KN.

Nat Commun. 2017 Aug 24;8(1):343. doi: 10.1038/s41467-017-00153-y.

12.

Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.

Gupta SK, Torrico Guzmán EA, Meenach SA.

Int J Cancer. 2017 Nov 15;141(10):2143-2153. doi: 10.1002/ijc.30913. Epub 2017 Aug 18.

PMID:
28771722
13.

Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.

Toivanen PI, Nieminen T, Laakkonen JP, Heikura T, Kaikkonen MU, Ylä-Herttuala S.

Sci Rep. 2017 Jul 17;7(1):5525. doi: 10.1038/s41598-017-05876-y.

14.

Ratiometric in vivo auditioning of targeted silver nanoparticles.

Toome K, Willmore AA, Paiste P, Tobi A, Sugahara KN, Kirsimäe K, Ruoslahti E, Braun GB, Teesalu T.

Nanoscale. 2017 Jul 20;9(28):10094-10100. doi: 10.1039/c7nr04056c.

PMID:
28695222
15.

NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides.

Leng Q, Woodle MC, Mixson AJ.

Drugs Future. 2017 Feb;42(2):95-104. doi: 10.1358/dof.2017.042.02.2564106.

16.

Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability.

Yu H, Wang C, Feng L, Cai S, Liu X, Qiao X, Shi N, Wang H, Wang Y.

Sci Rep. 2017 Jun 1;7(1):2600. doi: 10.1038/s41598-017-02050-2.

17.

Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.

Gao N, Bozeman EN, Qian W, Wang L, Chen H, Lipowska M, Staley CA, Wang YA, Mao H, Yang L.

Theranostics. 2017 Apr 10;7(6):1689-1704. doi: 10.7150/thno.18125. eCollection 2017.

18.

Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.

Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, Clise-Dwyer K, Herrmann AC, Alatrash G, Toniatti C, Hanash SM, Ma Q, Molldrem JJ.

J Biol Chem. 2017 Jun 16;292(24):10295-10305. doi: 10.1074/jbc.M116.773051. Epub 2017 May 3.

PMID:
28468826
19.

Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.

Ikemoto H, Lingasamy P, Anton Willmore AM, Hunt H, Kurm K, Tammik O, Scodeller P, Simón-Gracia L, Kotamraju VR, Lowy AM, Sugahara KN, Teesalu T.

Tumour Biol. 2017 May;39(5):1010428317701628. doi: 10.1177/1010428317701628.

20.

Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier.

Ruoslahti E.

J Clin Invest. 2017 May 1;127(5):1622-1624. doi: 10.1172/JCI93955. Epub 2017 Apr 17.

PMID:
28414298

Supplemental Content

Support Center